Forte Biosciences (FBRX) Capital Expenditures (2016 - 2025)
Forte Biosciences (FBRX) reported Capital Expenditures of $55000.0 for Q3 2025, down 9.84% quarter-over-quarter from $61000.0 in Q1 2025.
Forte Biosciences (FBRX) Capital Expenditures (2016 - 2025) Analysis & Trends
Forte Biosciences (FBRX) has 7 years of Capital Expenditures data on file, last reported at $55000.0 in Q3 2025.
- Capital Expenditures for Q3 2025 came in at $55000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $55000.0 (down 40.22% YoY), and the FY2025 annual result was $116000.0, up 213.51% from the prior year.
- Capital Expenditures declined to $55000.0 in Q3 2025 per FBRX's latest filing, from $61000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $61000.0 in Q1 2025 and troughed at $6000.0 in Q1 2024.
- A 3-year average of $42200.0 and a median of $55000.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures slumped 46.55% in 2024, then surged 916.67% in 2025.
- A 3-year view of Capital Expenditures shows it stood at $58000.0 in 2023, then tumbled by 46.55% to $31000.0 in 2024, then jumped by 77.42% to $55000.0 in 2025.
- Business Quant data shows FBRX's Capital Expenditures at $55000.0 in Q3 2025, $61000.0 in Q1 2025, and $31000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Dec 31, 2019 | 89,000.00 |
| Dec 31, 2019 | 89,000.00 |
| Sep 30, 2019 | -184,000.00 |
| Sep 30, 2019 | -184,000.00 |
| Jun 30, 2019 | 124,000.00 |
| Jun 30, 2019 | 124,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Dec 31, 2018 | -328,000.00 |
| Dec 31, 2018 | -328,000.00 |